Evoke plc (LON:EVOK – Get Free Report)’s share price traded down 10% on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
A number of analysts recently weighed in on EVOK shares. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank cut their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th.
Read Our Latest Stock Analysis on EVOK
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Research analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current year.
Insiders Place Their Bets
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
About Evoke
Recommended Stories
- Five stocks we like better than Evoke
- Transportation Stocks Investing
- MarketBeat Week in Review – 03/24 – 03/28
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.